# Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response

> **NCT04326803** · PHASE4 · UNKNOWN · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 200 (estimated)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Hepatitis B recombinant vaccine

## Key facts

- **NCT ID:** NCT04326803
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326803, "Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04326803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*